Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for aTyr Pharma, Inc. (ATYR : NSDQ)

• Company Description    aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States. Number of Employees: 59

• Price / Volume Information    Yesterday's Closing Price: $0.78 Daily Weekly Monthly 20 Day Moving Average: 1,825,715 shares Shares Outstanding: 97.99 (millions) Market Capitalization: $76.73 (millions) Beta: 0.60 52 Week High: $7.29 52 Week Low: $0.64 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.40% -5.24% 12 Week -17.83% -19.15% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10240 Sorrento Valley Road Suite 300 - SAN DIEGO,CA 92121 USA ph: 858-731-8389 fax: 858-731-8394 investorrelations@atyrpharma.com http://www.atyrpharma.com

• General Corporate Information    Officers Sanjay S. Shukla - President; Chief Executive Officer and Director Timothy P. Coughlin - Chairman of the Board Jill M. Broadfoot - Chief Financial Officer Eric Benevich - Director John K. Clarke - Director Peer Information aTyr Pharma, Inc. (CORR.) aTyr Pharma, Inc. (RSPI) aTyr Pharma, Inc. (CGXP) aTyr Pharma, Inc. (BGEN) aTyr Pharma, Inc. (GTBP) aTyr Pharma, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 002120202 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/12/26 Share - Related Items Shares Outstanding: 97.99 Most Recent Split Date: 7.00 (0.07:1) Beta: 0.60 Market Capitalization: $76.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.51 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.96 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -13.04% vs. Previous Quarter: -18.18% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - -100.36 06/30/25 - -93.69 ROA 12/31/25 - - 09/30/25 - -74.70 06/30/25 - -68.83 Current Ratio 12/31/25 - - 09/30/25 - 5.93 06/30/25 - 5.63 Quick Ratio 12/31/25 - - 09/30/25 - 5.93 06/30/25 - 5.63 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -39,540.53 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - 0.82 06/30/25 - 0.84 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.01 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.49 06/30/25 - 0.80

Powered by Zacks Investment Research ©